Before approving a new drug, the FDA typically requires companies to conduct a type of study called a randomized controlled trial, in which study participants are allocated by chance to groups that either receive the drug, or are administered a placebo
About the Experts Vishwanath Venketaraman, Ph.D., is a professor of microbiology and immunology at the Western University of Health Sciences in Pomona, CA
Long-Term Injury Prevention Recovering from an adductor strain provides an opportunity to address the factors that contributed to injury in the first place
Elucidating the precise mechanisms linking genetic and viral risk factors in human-relevant contexts is critical
The blue curve represents a healthy or early-injury lung: broad balanced zone, high efficiency
Proper peptide handling during shipping affects quality